Powering the next generation of natural health products

Glow Lifetech (CSE:GLOW) is an ingredient technology company on a mission to revolutionize the effectiveness of natural health products.

Corporate overview

Operating at the intersection of food, pharma and technology, Glow Lifetech is focused on developing and producing high-performance, water-soluble natural ingredients, using its award-winning MyCell^® delivery system technology.

MyCell^® is a cutting-edge delivery system that optimizes the absorption, bioavailability and effectiveness of natural active compounds including vitamins, cannabinoids and botanicals, using only 100% natural, food-grade components.

With its advanced technology and robust portfolio of enhanced ingredients, Glow is powering a new era of more effective, fast-acting, and great tasting functional foods, beverages, supplements, and personal care products.

Glow Lifetech is publicly listed in Canada, U.S. and Europe under tickers (CSE: GLOW, OTCQB: GLWLF, FSE:9DO.

Enormous, multifaceted growth potential: Glow’s technology and product portfolio is disrupting several large, high-growth verticals across the natural health industry including vitamins, cannabis, botanicals and more, which comprise an $800B market globally.
Proven, pharma-grade technology: The company’s MyCell^® Technology is a Swiss designed technology and 2018 winner of the prestigious CPhI pharma award. It has been researched and validated in clinical studies & successfully commercialized in Europe.
Portfolio of industry-leading products: Glow has a robust pipeline of already developed products that are ready for commercialization. Its flexible technology platform supports endless existing and emerging natural compounds.
Flexible, asset-light operations: The company has an efficient network of factor-in-factory manufacturing and importing partnerships that is built to scale, minimize costs, and expedite speed to market.
Low valuation with substantial upside: Glow is an early-stage company well positioned for growth; with a versatile technology platform that creates optionality for value creation across several high-growth natural health categories.

Investor Booklet

Request our latest investor booklet for more information on our company road map, earnings, clinical studies and more.

Latest news

View All News

12 . 12 . 2024

Glow Lifetech Announces Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Read More
02 . 12 . 2024

Glow Lifetech Reports 49% Q/Q Revenue Growth, 73% Gross Margins, and Strengthened Balance Sheet in Q3 2024

Read More
29 . 11 . 2024

Glow Lifetech Announces Closing of Non-Brokered Private Placement Offering of Units and Debt Settlement

Read More
05 . 11 . 2024

Glow Lifetech Announces Non-Brokered Private Placement Offering of Units and Debt Settlement

Read More

Sign up for our investor newsletter

Sign up for our investor newsletter to stay up to date with all of the latest investor news, financial information and more.

Financial Documents

View SEDAR Filings

Fiscal Year

Q1 2024

Q2 2024

Q3 2024

GLOW(CSE)

Our team

Tom Gladwell, PhD Chief Operations Officer

Rob Carducci Chief Executive Officer & Director

Josh Bald Chief Financial Officer

Brian Diamond Director of Manufacturing

Daniel Proska Board of Directors

James Van Staveren Board of Directors

Have investment questions?

Get in touch with our investor relations team for more information or reach out directly at: ir@glowlifetech.com or 1-855-442-GLOW (4569)

Investor
F.A.Q

When was Glow founded?: Glow was founded in 2019, originally as a subsidiary of Scryb Inc. ($SCYB) formerly known as Relay Medical Corp.
Where is Glow’s corporate headquarters?: Our corporate headquarters is at: 65 International Blvd., Suite 206, Toronto, Ontario, CA M9W 6L9.
When did Glow go public?: Glow became a publicly traded company through a reverse takeover, or RTO, on March 15, 2021.
What exchanges does Glow trade on and what is Glow’s ticker symbol?: Glow Lifetech Corp. stock trades on the Canadian Securities Exchange under the ticker symbol “GLOW”, the OTCQB under the ticker “GLWLF”, and the FSE under ticker “9DO”.
How can I buy the stock?: Our stock can be purchased by contacting a registered stock broker or through an online stock brokerage service for self-directed investors.
Where can I find information on Glow’s filings with the Canadian Securities Administrators" or "CSA”?: Our public securities filings are available on SEDAR.
Who should I contact for investor related questions?: For investor related questions, please contact ir@glowlifetech.com.